How It Is Given
Getting Started
Most Common
Safety and risks
Risk here is not one number. It depends on your age when you start, how long since your last period, which hormones you take, in which form, and for how long. Six pages, each dealing with one of those honestly. Discussed in full before anything is prescribed in Los Angeles.
The WHI legacy
Much of what a woman in Los Angeles has absorbed about hormone therapy traces back to one press conference held before her own symptoms started. The Women's Health Initiative was halted early and reported in July 2002. Prescriptions fell by more than half within a year, and a generation of women went untreated on the strength of a press conference.
The finding was real but narrow. The average participant was 63 years old and more than ten years past menopause, and most were taking oral conjugated estrogen with a synthetic progestin. That is not the woman who walks into a menopause clinic at 49 asking about a patch.
Re-analysis by age has been consistent since. For women starting near menopause, absolute risks are small and several outcomes move the other way. We go through those numbers with you rather than around them. There is more in about the clinic, hrt risks and benefits and early and surgical menopause go further into it. Ask for the age-stratified numbers at your Los Angeles consultation, and we will show them next to the 2002 figures rather than instead of them.
How we reduce risk
Before 60, or within ten years of your last period. This single factor moves the balance more than anything else on this list.
A patch or gel bypasses first-pass liver metabolism and has not shown the clot signal that oral estrogen carries.
Enough to control symptoms, no more. We titrate rather than starting high and hoping it settles.
At three months, then annually. Screening continues as normal: mammograms, blood pressure and cervical screening on schedule.
All safety topics
Four of the six. Each one takes a single concern and gives you the actual numbers rather than a reassurance.
The balance sheet: what goes up, what goes down, and by how much.
Learn moreWhat the data shows for combined therapy versus estrogen alone.
Learn moreWhy the route the medicine takes into your body changes this one.
Learn moreThe contraindications, and what needs investigating before anything is prescribed.
Learn moreA review at three months, then annually.
Learn moreBreast tenderness, spotting and bloating are common in the first three months and usually settle.
Learn moreCommon questions
Answered the way a clinician would answer them, not the way a brochure would.
Patient reviews
I had been waking three or four times a night for two years and had been told it was just stress. The consultation actually went through my cycle history. Six weeks on a patch and I am sleeping through.
What I wanted was someone who would talk about the risks honestly rather than sell me something. They walked through the clot data and why a patch suited me better than tablets.
The brain fog was the part nobody warned me about. Having a clinician tell me it was a recognized symptom and not early dementia was worth the appointment on its own.
It took two dose changes before things settled, which they had told me upfront might happen. The three-month review was booked before I left the first appointment.
From the blog
Next step
Family history, clot history, blood pressure and how long since your last period. Those four things turn a general risk statistic into a number that applies to you.
Consultations are by appointment. Prescriptions are issued only where clinically appropriate.